Digestive and Liver Disease
Volume 42, Issue 4 , Pages 261-271 , April 2010

Polycystic liver diseases

  • P. Onori

      Affiliations

    • Experimental Medicine, University of L’Aquila, L’Aquila, Italy
  • ,
  • A. Franchitto

      Affiliations

    • Dept Human Anatomy, University of Rome “La Sapienza”, Rome, Italy
  • ,
  • R. Mancinelli

      Affiliations

    • Dept Human Anatomy, University of Rome “La Sapienza”, Rome, Italy
  • ,
  • G. Carpino

      Affiliations

    • Dept Health Science, University of Rome “Foro Italico”, Italy
  • ,
  • D. Alvaro

      Affiliations

    • Gastroenterology, Polo Pontino, University of Rome “La Sapienza”, Rome, Italy
  • ,
  • H. Francis

      Affiliations

    • Research, Central Texas Veterans Health Care System, USA
  • ,
  • G. Alpini

      Affiliations

    • Research, Central Texas Veterans Health Care System, USA
    • Scott & White Digestive Disease Research Center, Texas A&M Health Science Center, College of Medicine, USA
  • ,
  • E. Gaudio

      Affiliations

    • Dept Human Anatomy, University of Rome “La Sapienza”, Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0649918060; fax: +39 0649918062.

Received 23 November 2009 ,Accepted 7 January 2010.

  • Image Result

    Abdominal computed tomography (axial and frontal orientation respectively) of an adult with ADPCLD showing extensive cyst formation in liver parenchyma (images kindly provided by Prof. C. Catalano and

    Abdominal computed tomography (axial and frontal orientation respectively) of an adult with ADPCLD showing extensive cyst formation in liver parenchyma (images kindly provided by Prof. C. Catalano and Dr. V. Cardinale).

  • Image Result
    Diagram of the genetics of polycystic liver disease in its autosomic dominant form, with mutation on the genes PKD1, PKD2, PRKCSH and SEC63.

    Diagram of the genetics of polycystic liver disease in its autosomic dominant form, with mutation on the genes PKD1, PKD2, PRKCSH and SEC63.

  • Image Result
    Diagram of the genetic of polycystic liver disease in its subtype autosomic recessive linked to modifications in the gene PKHD1 that codes for the protein fibrocystin.

    Diagram of the genetic of polycystic liver disease in its subtype autosomic recessive linked to modifications in the gene PKHD1 that codes for the protein fibrocystin.

  • Image Result
    SEM of luminal surface of a small hepatic cyst of ADPKD liver. The epithelium lining small cyst (1cm maximum diameter) shows a carpet of regular microvilli and typical primary cilia comparable with a

    SEM of luminal surface of a small hepatic cyst of ADPKD liver. The epithelium lining small cyst (1cm maximum diameter) shows a carpet of regular microvilli and typical primary cilia comparable with a normal biliary epithelium. Bar 10μm.

  • Image Result
    SEM of epithelial surface of a cyst with a 2–2.5cm maximum diameter shows less dense microvilli and clear areas become visible. The cilium is absent or shorter than the typical structure and often sho

    SEM of epithelial surface of a cyst with a 2–2.5cm maximum diameter shows less dense microvilli and clear areas become visible. The cilium is absent or shorter than the typical structure and often showed alteration of the apical zone. In the box, at higher magnification a short and abnormal cilium is evident. Bar 2μm.

  • Image Result
    Diagram depicting the genetic basis of cyst formation in ADPCLD. The biliary epithelium in a normal person has both alleles of PKD genes. In patients with ADPCLD, there is a germ-line mutation of one

    Diagram depicting the genetic basis of cyst formation in ADPCLD. The biliary epithelium in a normal person has both alleles of PKD genes. In patients with ADPCLD, there is a germ-line mutation of one of the alleles (‘first hit’). Some cells within the duct acquire a mutation in the second allele (‘second hit’), resulting in increased proliferative activity in these cells, leading ultimately to cyst formation. The cells lining these cysts are monoclonal and are homozygous for PKD mutation.

  • Image Result
    Immunohistochemistry for ER-α (A), ER-β (B), IGF-1 (C), IGF1-R (D), FSH (E), FSHR (F), VEGF-A (G), and VEGF-C (H) in hepatic cysts from patients with ADPCLD. Cholangiocytes of reactive bile ducts clos

    Immunohistochemistry for ER-α (A), ER-β (B), IGF-1 (C), IGF1-R (D), FSH (E), FSHR (F), VEGF-A (G), and VEGF-C (H) in hepatic cysts from patients with ADPCLD. Cholangiocytes of reactive bile ducts close to the cysts are positive for both estrogen receptors. The epithelium lining small and large cysts showed strong positivity for ER-α and ER-β located at cytoplasmic levels. Both IGF1 and its receptor showed positive immunolocalisation in biliary epithelium. The expression of the hormone FSH is also present in both small and large cysts. A stronger immunolocalisation is found for FSHR in the biliary epithelium that lines hepatic cysts. Furthermore, biliary epithelium of small and large cysts shows an high positivity for VEGF-A and VEGF-C, that play an important role in the growth of cysts and in the progression of PCLD. Original magnification 20×.

  • Image Result
    Immunofluorescence in immortalized cell cultures from normal rat cholangiocytes (NRC), normal human cholangiocytes (H69) and cholangiocytes from hepatic cysts (LCDE) shows the presence of positivity f

    Immunofluorescence in immortalized cell cultures from normal rat cholangiocytes (NRC), normal human cholangiocytes (H69) and cholangiocytes from hepatic cysts (LCDE) shows the presence of positivity for FSH and FSHR. Original magnification 40×. Bar 200μm.

  • Image Result
    Diagram depicting putative pathways in polycystic liver disease. Dysregulation of [Ca2+]i, increased concentrations of cAMP and upregulation of FSH, IGF1, VEGF, and TNFα occur in cells bearing PKD mut

    Diagram depicting putative pathways in polycystic liver disease. Dysregulation of [Ca2+]i, increased concentrations of cAMP and upregulation of FSH, IGF1, VEGF, and TNFα occur in cells bearing PKD mutations. Increased accumulation of cAMP in polycystic livers may result from disruption of the polycystin complex, as PC1 may act as a Gi protein-coupled receptor and stimulation of Ca2+ inhibitable AC6. Increased cAMP levels contribute to cystogenesis by stimulating chloride and fluid secretion. In addition, cAMP stimulates mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK) signalling in cyst-derived cells.

PII: S1590-8658(10)00010-1

doi: 10.1016/j.dld.2010.01.006

Digestive and Liver Disease
Volume 42, Issue 4 , Pages 261-271 , April 2010